Anti-hypertension drug may improve schizophrenia symptoms

May 9, 2013 by Raquel Maurier

(Medical Xpress)—An anti-hypertension drug administered intravenously for a single four-hour treatment resulted in dramatic improvements of symptoms for people living with schizophrenia, according to newly published findings from clinician scientists at the University of Alberta's medical school and their colleagues in Brazil.

The results from the small clinical trial were published May 8 in the peer-reviewed journal, JAMA Psychiatry. The study involved 20 people with taking currently available . Ten received placebo treatments; the other 10 received low doses of the anti- sodium nitroprusside. Those taking the drug, which has been around since the 1800s, experienced dramatic improvements in symptoms, such as fewer (episodes of hearing voices), and less anxiety, depression and withdrawal. These improvements lasted for a month.

The small study was conducted at a university teaching hospital in Brazil, where principal investigator James Hallak works. The other principal investigator is Serdar Dursun, a researcher with the Faculty of Medicine & Dentistry who works in the Department of Psychiatry at the U of A.

In previous research in which Dursun was involved, his team saw promising results in lab models given the drug, originally marketed for treating severely high blood pressure. He was curious whether similar results would occur in people and teamed up with a colleague from Brazil to find out.

"This opens a new line of research for the treatment of schizophrenia," says Dursun. "Such rapid improvement of symptoms of schizophrenia could be very important to help patients in acute care and emergency settings."

Research team members believe the drug modifies how two chemical messengers in the brain interact.

Dursun and his colleagues are continuing their research in this area. They hope to secure more funding to conduct larger-scale .

Explore further: Researchers identify new drug target for schizophrenia

Related Stories

Researchers identify new drug target for schizophrenia

August 13, 2012

(Medical Xpress) -- Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave ...

Patients with schizophrenia benefit from 'adherence therapy'

March 4, 2013

(Medical Xpress)—More than half of all patients suffering from schizophrenia do not take antipsychotic medication as prescribed, although this is essential for their effective treatment, according to research published ...

Improving the search for new schizophrenia treatments

April 5, 2013

(Medical Xpress)—Controlling the symptoms of schizophrenia is the job of antipsychotic drugs which block a set of specific neural signals. But the way these drugs work can lead to a host of severe and debilitating long-term ...

Recommended for you

Repeating aloud to another person boosts recall

October 6, 2015

Repeating aloud boosts verbal memory, especially when you do it while addressing another person, says Professor Victor Boucher of the University of Montreal's Department of Linguistics and Translation. His findings are the ...

Men more likely to be seen as 'creative thinkers'

September 28, 2015

People tend to associate the ability to think creatively with stereotypical masculine qualities, according to new research published in Psychological Science, a journal of the Association for Psychological Science. The findings ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.